Guided Therapeutics (GTHP) Asset Writedowns and Impairment (2016 - 2026)
Guided Therapeutics (GTHP) posted Asset Writedowns and Impairment of $30000.0 for Q4 2025, up 1400.0% sequentially from $2000.0 in Q3 2025, and up 314.29% YoY from $7241.4 in Q4 2024.
Guided Therapeutics (GTHP) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends
Guided Therapeutics has reported Asset Writedowns and Impairment for 6 years, with the latest figure at $30000.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 314.29% year-over-year to $30000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26000.0 (up 128.26% YoY) and the FY2025 annual result came in at $33000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment grew to $30000.0 in Q4 2025 per GTHP's latest filing, from $2000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $30000.0 in Q4 2025 and troughed at -$14000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Dec 31, 2020 | -86,000.00 |
| Dec 31, 2020 | -86,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Sep 30, 2017 | 333,000.00 |
| Sep 30, 2017 | 333,000.00 |